LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Carrum Health, GRAIL strike up partnership to offer cancer test to employers

...

NHS launches World’s Largest Trial of Cancer Blood Test

New multi-cancer early detection blood test study opens

Drive to end cancer could pioneer diagnostic technology

GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test

Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test

GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease

GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

  • 1
  • 2
  • 3
  • 4
  • 5
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference

  • RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

  • Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

  • Inbound Health launches at-home post-surgery care

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn